Precision Medicine

Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.

Blood disorders may be proving ground for gene-editing technique

Editing the human genome has been a stand-by in sci-fi movies for decades. But Crispr—the relatively easy and inexpensive editing technique, with emphasis on relatively—has led many to believe such a disease-curing technology is within reach.

Thumbnail

Researchers test patch that releases blood thinners to combat thrombosis

Researchers have developed a patch that can monitor a patient’s condition and release blood-thinning medication to avoid dangerous blood clots.

Patient-centered medical research could increase pharma influence

Patient input is now an essential part of medical research, but advocates are worried that with participation comes the risk of being “co-opted” by pharmaceutical companies.  

HeartLogic predicts 70 percent of heart failure events a month in advance

Heart failure sends one million people to the hospital every year and even with precautionary measures, many of these patients are readmitted to the hospital within 30 days. Researchers have developed a system of sensors that may predict heart failure to prepare patients in advance for treatment.

Medicare privatization plan would face Democratic resistance

A push by the Republican-controlled Congress to privatize Medicare won’t be supported with Democratic votes, according to House Democratic Leader Nancy Pelosi. 

Freeze! Hypothermic medicine may save trauma patients

In normal circumstances hypothermia is something to be avoided, but the use of cold temperatures has become a staple at Baltimore's R Adams Cowley Shock Trauma Center.

Telemedicine consultations help babies breathe easily

Time is of the essence when newborn babies experience respiratory problems. For rural or unequipped hospitals, these high-risk births are especially challenging. Telemedicine is one avenue for these hospitals to consult physicians from all over the world and provide timely care to these tiny patients.

Bioartificial kidney gets its “living membrane”

Researchers have come one step closer to developing a bioartificial kidney by producing the “living membrane” portion of the kidney. The latest in the development is set to be presented at American Society of Nephrology (ASN) Kidney Week 2016. 

Around the web

CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.